Bio Medica Laboratories (NSE:BMLL) OCF Margin %: -9.61% (As of Mar. 2025)


NSE:BMLL Bio Medica Laboratories Ltd NSE:BMLL
14 GF Score
Price ₹144.10
! 2 Warning Signs
View Full Analysis

What is Bio Medica Laboratories OCF Margin %?

Bio Medica Laboratories NSE:BMLL +0.49% 14 OCF Margin % is -9.61% as of Mar. 2025. GuruFocus rates NSE:BMLL with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Bio Medica Laboratories ranks worse than 70.55% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Bio Medica Laboratories's Cash Flow from Operations for the six months ended in Mar. 2025 was ₹-36.7 Mil. Bio Medica Laboratories's Revenue for the six months ended in Mar. 2025 was ₹382.0 Mil. Therefore, Bio Medica Laboratories's OCF Margin % for the quarter that ended in Mar. 2025 was -9.61%.

As of today, Bio Medica Laboratories's current OCF Yield % is -2.03%.

The historical rank and industry rank for Bio Medica Laboratories's OCF Margin % or its related term are showing as below:

NSE:BMLL' s OCF Margin % Range Over the Past 10 Years
Min: -9.61   Med: 10.65   Max: 14.13
Current: -9.61

During the past 3 years, the highest OCF Margin % of Bio Medica Laboratories was 14.13%. The lowest was -9.61%. And the median was 10.65%.

NSE:BMLL's OCF Margin % is ranked worse than
70.55% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.82 vs NSE:BMLL: -9.61

Bio Medica Laboratories OCF Margin % Related Terms

Bio Medica Laboratories OCF Margin % Historical Data

* Premium members only.

The historical data trend for Bio Medica Laboratories's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio Medica Laboratories OCF Margin % Chart

Bio Medica Laboratories Annual Data
Trend Mar23 Mar24 Mar25
OCF Margin %
14.13 10.65 -9.61

Bio Medica Laboratories Semi-Annual Data
Mar23 Mar24 Mar25
OCF Margin % 14.13 10.65 -9.61

NSE:BMLL vs ISRG, BDX, MDLN: OCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, Bio Medica Laboratories's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio Medica Laboratories OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio Medica Laboratories's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Bio Medica Laboratories's OCF Margin % falls into.


NSE:BMLL
14GF Score
Bio Medica Laboratories Ltd NSE:BMLL
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio Medica Laboratories OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Bio Medica Laboratories's OCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-36.717/381.952
=-9.61 %

Bio Medica Laboratories's OCF Margin for the quarter that ended in Mar. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=-36.717/381.952
=-9.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -9.61% mean?
Bio Medica Laboratories (NSE:BMLL) has a OCF Margin % of -9.61% as of Mar. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bio Medica Laboratories and its competitors. According to the industry distribution chart, Bio Medica Laboratories ranks #575 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 70.6%.
Is Bio Medica Laboratories' OCF Margin % too high?
Bio Medica Laboratories' current OCF Margin % is -9.61%. Based on the distribution chart, Bio Medica Laboratories ranks #575 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Bio Medica Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Bio Medica Laboratories' OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bio Medica Laboratories ranks #575 out of 815 companies for OCF Margin %. This places Bio Medica Laboratories in the lower half of its industry. The industry median OCF Margin % is 5.82. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.82, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bio Medica Laboratories and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio Medica Laboratories's current OCF Margin % is -9.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Medica Laboratories stock overvalued right now?
Bio Medica Laboratories (NSE:BMLL) has a current OCF Margin % of -9.61%. The current OCF Margin % is -9.61%. Bio Medica Laboratories' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Bio Medica Laboratories (NSE:BMLL), the current OCF Margin % is -9.61% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio Medica Laboratories Business Description

Address Sanwer Road, Plot No. 11B-11C, Sector-E, Industrial Area, Industrial Estate - Indore, Indore, MP, IND, 452015
Bio Medica Laboratories Ltd is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences. The majority of revenue is derived from the sales of Liquid injections. Geographically, it operates predominantly in India, and internationally, it exports to Afghanistan.
14GF Score

Get the complete analysis for NSE:BMLL

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹144.10
Price